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ABSTRACT Cyclic nucleotide binding domain (CNBD) is a ubiquitous domain of effector 
proteins involved in signalling cascades of prokaryota and eukaryota. CNBD activation by cyclic 
nucleotide monophosphate (cNMP) is studied well in case of several proteins. However, this 
knowledge is hardly applicable to cNMP-modulated cation channels. Despite the availability of 
CNBD crystal structures of bacterial cyclic nucleotide-gated (CNG) and mammalian 
hyperpolarization-activated cyclic nucleotide-modulated (HCN) channels in presence and absence 
of the cNMP, the full understanding of CNBD conformational changes during activation is 
lacking. Here, we describe a novel CNBD dimerization interface found in crystal structures of 
bacterial CNG channel MlotiK1 and mammalian cAMP-activated guanine nucleotide-exchange 
factor Epac2. Molecular dynamics simulations show that the found interface is stable on the 
studied timescale of 100 ns, in contrast to the dimerization interface, reported previously. 
Comparisons with cN-bound structures of CNBD show that the dimerization is incompatible with 
cAMP binding. Thus, the cAMP-dependent monomerization of CNBD may be an alternative 
mechanism of the cAMP sensing. Based on these findings, we propose a model of the bacterial 
CNG channel modulation by cAMP. 
 
Keywords: cyclic-nucleotide binding domain, CNG channel, Epac2, channel 
gating 
 
Abbreviations: CNBD, Cyclic nucleotide binding domain; cNMP, cyclic nucleotide 
monophosphate; cAMP, cyclic adenosine 
monophosphate; CNG channel, cyclic nucleotide-gated 
channel; HCN channel, hyperpolarization-activated 
cyclic nucleotide-modulated channel; MD, molecular 
dynamics; RMSD, root mean square deviation; PCA, 
principal components analysis. 
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Introduction 
The cyclic nucleotide binding domain (CNBD) is a part of many cAMP-regulated 
proteins [1]. Its function has been well studied for catabolite activator protein 
(CAP), protein kinase A (PKA) and guanine nucleotide-exchange factor (GEF) 
Epac2. CAP is organized as a dimer, with its interface being on the CNBD helix C 
[2]. Binding of cAMP induces a coil-to-helix transition in CNBD-distal end of 
CNBD helix C, and consequent rearrangement of DNA-binding domain, which 
results in the increase in DNA affinity [3]. In PKA, binding of cAMP to the 
regulatory subunit results in dissociation of subunits and activation of the catalytic 
subunit [4]. As for Epac2, it functions as a monomer, but there are two CNBD 
domains in it (CNBD-A and CNBD-B). In the inactive form, CNBD-A and 
CNBD-B are bound to each other and occlude the binding site of the small G 
protein Rap. Upon introduction of cAMP, CNBD-B moves away from the Rap 
binding site and Epac2 becomes active [5]. 
Besides aforementioned proteins, there exist a number of tetrameric cation 
channels whose conductivity is modulated by cyclic nucleotides. These channels 
lie at heart of many cellular processes and were extensively studied by various 
biophysical techniques [6]. Important insights into the channels’ function were 
gained from structural studies [6]. Crystallographic structures revealed not only 
the tertiary structure of channel CNBDs, but also their multimeric states. CNBD 
from bacterial cyclic nucleotide gated (CNG) channel MlotiK1 crystallizes as a 
dimer with non-crystallographic symmetry axis [7, 8] and the structure of the 
monomers resembles that of CNBDs from other proteins. Because the CNBD was 
co-purified with a bound cAMP, which was difficult to remove by dialisys, the 
crystallographic structure of the cAMP-free CNBD was determined for mutants 
with hampered cyclic nucleotide binding [7, 8]. Though some cAMP-dependent 
structural rearrangements were revealed, the findings did not result in a definitive 
hypothesis on how the channel activation could proceed [1, 7]. NMR studies 
provided complementary information on the CNBD structure in solution, both in 
presence and absence of cAMP, and found no evidence of dimerization [9, 10]. 
Finally, the 16 Å resolution electron microscopy structure of the whole-length 
cAMP-bound MlotiK1 channel revealed that in that state the CNBDs are 
completely dissociated [11]. As for more complex eukaryotic cyclic nucleotide-
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gated (CNG) channels and hyperpolarization-activated cyclic nucleotide-
modulated (HCN) channels, the crystallographic structures of the cytoplasmic 
parts revealed similar CNBD structure and tetrameric overall assembly, which 
proceeds via the interaction between the C-linkers [12–14]. However, no large-
scale structural rearrangements, which could result in channel modulation, were 
detected between the cNMP-free and cNMP-bound structures. Thus, despite the 
extensive studies, the full understanding of the cyclic nucleotide modulation of 
both prokaryotic and eukaryotic cation channels has not been reached. 
Here, we describe a novel CNBD dimerization interface, present in two different 
crystallographic structures, the first one is of MlotiK1 CNBD domain R307W 
mutant with hampered cAMP binding, PDB ID  3CO2 [8], and the other one is of 
Epac2, PDB IDs 1O7F [15] and 2BYV [16]. This dimerization is incompatible 
with cAMP binding, and thus the CNBD monomerization upon binding of cAMP 
may be a mechanism of the cyclic nucleotide sensing. We have studied the 
stability of the MlotiK1 CNBD homodimer and Epac2 CNBD heterodimer by 
means of molecular dynamics. No structural rearrangements were observed during 
the simulations. The dimers were stable on the studied timescale. As a reference, 
we have also simulated the other MlotiK1 CNBD dimerization interface, 
described in the previous studies, which is observed in both the cAMP-bound and 
the cAMP-free structures [7, 8]. This interface fluctuates excessively and partially 
dissociates during the simulations.  On the basis of our findings, we discuss the 
possibility of CNBD dimerization in the physiological context and propose the 
mechanism of the bacterial CNG channel gating, based on cAMP-disrupted 
dimerization of its CNBDs. 
Materials and Methods 
For molecular dynamics simulations the models were immersed in a water box 
with 8 Å padding. Sodium and chloride ions were added at a total concentration of 
0.2 M in such amounts that the total charge of a system would be equal to zero. 
Before the production run, the systems were equilibrated in three steps. First, the 
energy of the system was minimized using standard algorithms [17, 18]. After 
that, the solvent was equilibrated for 1 ps, with the protein atoms being restrained. 
Finally, the whole system was released and equilibrated for additional 1 ps.   
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Atomic coordinates for MlotiK1 CNBD dimers were taken from the structure of 
R307W mutant (PDB ID 3CO2 [8]) and the model was completed to contain 
residues 221-350. The residue W307 was mutated back to arginine in order to 
represent the wild-type protein using the psfgen utility [17], and the structure was 
equilibrated by the standard procedure. After the equilibration, R307 occupied the 
conformation similar to that observed in the experimental structures. Atomic 
coordinates for Epac2 CNBD dimer were taken from the PDB ID 1O7F [15]. 
Residues 13-167 were taken for CNBD-A, and 305-444 for CNBD-D. All the 
residues were assumed to be in their standard protonation states, based on by-
residue pKa values determined with PROPKA server [19]. In total, three 
molecular systems were prepared: the Epac2 CNBD heterodimer, the MlotiK1 
CNBD homodimer with the novel interface, and the MlotiK1 CNBD homodimer 
with a previously described interface. Each system was simulated for 100 ns at 
310 K with CHARMM27 parameters [20] with integration timestep of 2 fs. The 
Epac2 and MlotiK1 dimers with a novel interface were simulated using NAMD2 
version 2.7 [17], and the MlotiK1 dimer with a previously reported interface was 
simulated using GROMACS version 4.5.3 [18]. Bonds between the hydrogen 
atoms and the heavy atoms were kept rigid using the SHAKE algorithm. In namd2 
simulations, the temperature was maintained with the Langevin thermostat with 
the damping coefficient of 5 ps
-1
, and the pressure of 1 bar was maintained with 
the Langevin piston barostat with the following parameters: period of 100 fs, 
decay of 50 fs. In GROMACS simulations, the temperature was maintained with 
the Berendsen thermostat modified to reproduce the correct sampling of the 
temperature [21], and the pressure was maintained using the Parinello-Rahman 
scheme [22].  
The structures and the trajectories were analyzed using VMD [23]. For 
determination of the root mean square deviations of the atomic coordinates, all 
trajectory frames were aligned using the backbone atoms of both protomers. 
Principal components analysis (PCA) [24] of the mass-weighted covariance 
matrix of the backbone atoms’ coordinates was conducted using the tools g_covar 
and g_anaeig of the GROMACS suite [18]. 
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Results and Discussion 
Analysis of the novel CNBD dimerization interface 
The interface is present in crystallographic structures of two different proteins,  
bacterial CNG channel MlotiK1 R307W mutant (PDB ID  3CO2 [8]) and human 
guanine nucleotide exchange factor Epac2 (PDB IDs 1O7F [15] and 2BYV [16]). 
The protomers are located slightly asymmetrically. There are two main 
interactions present (Fig. 1). First, there are extensive β-sheet-like interactions of 
strand 4 with 6’ and strand 6 with 4’ (prime denotes the other protomer in the 
dimer). It appears that the β-roll of one protomer continues into the β-roll of the 
second protomer. Second, there are numerous hydrophobic contacts between the 
internal surfaces of the β-strands 4 and 5. In case of MlotiK1 CNBD, the dimer is 
further stabilized by the contact between the N-terminal helix of one protomer and 
β-strands 4 and 5 of the other (Fig. 1, (a)). In case of Epac2 CNBD, the dimer is 
additionally stabilized by the contact between the region C-terminal to CNBD-A 
and β-roll of CNBD-B (Fig. 1, (b)).  
The described interfaces possess contact surface areas of 800 Å
2
 and 1100 Å
2
 in 
MlotiK1 and Epac2 CNBD dimers, correspondingly, as calculated by PISA server 
[25]. However, in both dimers the protomers are not independent in vivo. The only 
physiological form of the MlotiK1 chanel is tetrameric, with the distance between 
the N-terminal tails of CNBD domains in the range 10-20 Å, as judged from the 
crystallographic structure of the transmembrane part [26]. In Epac2 CNBD-A and 
CNBD-B are simply a part of the same polypeptide chain. It means that in both 
cases the local concentrations of the interacting protomers are extremely high, of 
the order of 10% v/v and higher. Thus, the usual expectations about the contact 
surface area of physiological interfaces (as e.g. in [27]) are not applicable here, as 
the local concentration of interacting partners in case of Epac2 and MlotiK1 is 
highly elevated, compared to the usual concentrations of the interacting proteins 
in cytosol, and the proteins would dimerize even when the association constants 
are lower than usual. The more thorough consideration of the effects arising with 
domain linking (tethering) may be found in [28].  
To sum up, from the general considerations it appears very plausible that the 
described dimerization takes place in physiological settings. 
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Incompatibility of the dimerization with cAMP binding 
The described dimers possess a very notable feature, which may be directly 
relevant for their function. Both dimers are observed in the absence of the 
CNBD’s ligand cAMP. Comparison with the cAMP-bound structures (PDB ID 
1VP6 for MlotiK1 CNBD [7] and PDB ID 3CF6 for Epac2 CNBD [29]) shows 
that the presence of cAMP is incompatible with the dimerization. First, the cAMP, 
bound to the first protomer, occludes the place of binding of the second protomer, 
and second, the movement of the C-helix, induced by cAMP binding, would result 
in the steric clash of this helix with the second protomer (Fig. 1). Thus, the 
dimerization via the analyzed interface is impossible in the presence of cAMP. 
We propose that the dissociation of CNBD dimers upon rise of the cAMP 
concentration may underlie the function of CNBD in the MlotiK1 and Epac2. 
Molecular dynamics simulations 
To analyze stability of the observed dimers on the atomic level, we conducted the 
molecular dynamics (MD) simulations. We simulated the MlotiK1 and Epac2 
CNBD dimers for 100 ns. Both dimers reveal a high degree of stability. The 
average RMSD values for the backbone atoms are 2.3 Å for MlotiK1 dimer and 
2.1 Å for Epac2 dimer, and RMSD values for the backbone atoms at the contact 
site are 1.8 Å for MlotiK1 dimer and 1.8 Å for Epac2 dimer. Time-dependence of 
the RMSD for both systems is shown in Fig. 2. 
Analysis of the dependence of the RMSD on residue number shows that on 
average all the residues of the simulated dimers behave similarly (Fig. 3). Outliers 
are the unstructured regions between the α-helices αA’ and αA of CNBD-A and α-
helices αA’’ and αA’ of CNBD-B of Epac2. However, these regions are distal to 
the dimerization interface and their increased mobility should not affect the 
dimerization. Also, the N- and C-termini of all proteins reveal greater mobility, 
which is expected for the exposed ends of a polypeptide chain. As for the contact 
site, its residues in both proteins do not display any increased mobility compared 
to other residues. Fluctuations of the backbone atoms are presented in Fig. 3. 
In MlotiK1 CNBD homodimer, the protomers are positioned slightly 
asymmetrically. As a consequence, the difference in mobilities of the pin between 
β-strands 4 and 5 (4-5 pin), and of the β-strands is observed. The 4-5 pin of the 
protomer B is exposed to the solvent, and reveals a higher mobility as compared 
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to the buried 4-5 pin of the protomer A (Fig. 3). Also, a small rearrangement of 
the 4-5 pin of the protomer B is observed for one MlotiK1 protomer. This may be 
ascribed either to MD artifacts or to the probable errors in the initial 
crystallographic model due to its relatively low resolution (2.9 Å).  
As for the Epac2 CNBD heterodimer, the fluctuations of the contact site residues  
of both protomers (β-strands 4 and 5) are similar. The 4-5 pin is much longer in 
CNBD-A, it does not reveal any secondary structure and it does not participate in 
the dimerization. As a consequence, it fluctuates stronger than the neighboring 
residues (Fig. 3). β-strands 4 and 5 of CNBD-A are also more mobile that those of 
CNBD-B, probably as a consequence of the mobile pin. 
To sum up, the molecular dynamics show that the CNBD dimers observed in 
crystallographic structures remain stable on the studied timescale, the residues of 
the contact sites fluctuate similarly to other residues, and thus the observed 
interaction is significant. 
Molecular dynamics simulations of the previously reported MlotiK1 
CNBD dimer 
Previously, it was proposed that the MlotiK1 may dimerize via the α-helices A’ 
and A [7, 8] (Fig. 4). However, this notion is challenged by a number of other 
studies [6, 9–11, 30]. Here, we test this dimerization interface by means of 
molecular dynamics. As the CNBDs are dissociated in the cAMP-bound state 
[11], we used the interface from the cAMP-free mutant crystallographic structure 
as a starting conformation (PDB ID 3CO2, [8]). The dimer reveals excessive 
fluctuations, which sometimes result in a partial dissociation (Fig. 4 and 5) of the 
protomers (for example, at the time mark ~61 ns). There, the interaction is 
reduced to the α-helices A’, and the contact area is of the order of 300 Å2.  
In order to further characterize dynamics of this dimer, we have carried out the 
principal components analysis [24] of the mass-weighted covariance matrix of the 
backbone atoms’ coordinates. The analysis reveals that the conformational 
changes are dominated by the first three modes (Fig. 5). There, the protomers 
move largely independently as they do not change their own conformations, but 
move relative to each other for as much as 20 Å during the trajectory (Fig. 5). The 
nature of the contacts between the protomers is changed dramatically (Fig. 5).  
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The situation is different for the novel type of dimerization. There, only the first 
mode somewhat corresponds to relative domain motions  (Fig. 5). However, its 
amplitude is lower than the amplitude of any of the first three modes of the 
previously reported dimer, and the dimerization interface is preserved. This mode 
is rather a result of the overall flexibility of CNBD. 
Thus, we conclude that the previously reported type of dimerization is probably 
unspecific and simply reflects the hydrophobic nature of the interface. It should 
also be noted, that in this interface the contact site surface area is lower than in the 
dimerization interface proposed above, ~600 Å
2
 versus 800 Å
2
 and 1100 Å
2
. The 
α-helices A’, which continue from the transmembrane helices S6, are directed 
almost opposite to each other (Fig. 4), whereas in the novel interface the α-helices 
A’ cross at much lower angle (90°, Fig. 3). To sum up, it appears that if the 
CNBD dimerization occurs, it is much more likely to proceed via the newly 
reported interface, described above, and not via the previously reported one. 
Implications for CNG Channels Gating 
Bacterial CNG channels consist of three domains: four-helical trans membrane 
(TM) voltage sensing-like domain, two-helical TM ion channel pore domain, and 
CNBD. Mammalian CNGs and homologous to them HCNs are more complex and 
have elongated N- and C-termini and, most important, a C-linker, consisting of 
several α-helices, between the pore domain and CNBD. Presence of this linker 
undoubtedly results in qualitative differences. There, the CNBD is no longer 
connected directly to the S6 helix of the ion pore, and the distance between the 
CNBD and the membrane is much larger. Moreover, the crystallographic 
structures of the cytoplasmic parts of HCN2 and HCN4 reveal tetrameric ring-like 
assemblies, where the interaction is mediated by the C-linker  [12, 14, 31]. 
Finally, the gating process itself is different in mammalian and bacterial CNG 
channels at least in one aspect: while in the former it is strictly cooperative (Hill 
coefficients in the range 3-4), in the latter it is not (Hill coefficients of ~1.5) [7, 8, 
6]. Thus, the differences between the mammalian and bacterial channels are 
significant, and we will limit ourselves to the discussion of only the bacterial 
CNG’s gating. 
The MlotiK1 CNBD has been extensively studied experimentally [7–11, 30, 32]. 
It is a general conclusion that this domain behaves as a monomer in solution [9, 
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10, 30]. However, as we have already pointed out, the concentration of the protein 
used in these experiments is of the order of 0.1% v/v, meanwhile in the 
physiological context in the functional tetrameric channel there are four CNBDs 
in a very close proximity, with the effective local concentration of the order of 10-
20% v/v. Thus, the proposed dimerization could easily go undetected in the 
experiments. Finally, we would like to make a remark about the study of 
Cukkemane et al. [30]. There, three different methods were used to determine the 
dissociation constant KD of cAMP (isothermal titration calorimetry, tryptophan 
fluorescence and 8-NBD-cAMP fluorescence). In these three techniques the 
authors used different protein concentrations (of the order of 50 μM ≈ 0.1% v/v, 5 
μM and 0.5 μM), perhaps unintentionally. The resulting KD were 107±11, 80 and 
67.8±8.7 nM, correspondingly [30]. The discrepancies between the determined KD 
values may result from the methodological differences between the techniques, 
but the other explanation is also possible: cAMP competes with the CNBD 
dimerization, and as a consequence, it has a higher apparent KD at higher CNBD 
concentrations. Thus, the experimental results do not contradict the proposition of 
MlotiK1 CNBD dimerization, and probably support it. 
The possibility of the cAMP-disrupted dimerization of CNBD allows us to 
formulate the hypothesis on the gating of MlotiK1. In the absence of cAMP, the 
CNBDs are in the dimeric form and the channel is closed (Fig. 6). Binding of 
cAMP prevents the CNBD dimerization. Thus, in presence of cAMP, the CNBD 
domains are completely separated, in accord with low resolution electron 
microscopy structure [11], and the channel is open (Fig. 6). 
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Conclusions 
In this study, we have described the novel dimerization interface of cyclic 
nucleotide-binding domains, which is disrupted in presence of cAMP. Two 100 ns 
molecular dynamics simulations of the dimers from different proteins demonstrate 
that the CNBD dimer is stable on this timescale, and that the contact residues 
preserve their positions. The previously reported interface, on the opposite, is 
found to be unstable during the 100 ns molecular dynamics simulation. Possibility 
of cAMP-disrupted dimerization of CNBD allows us to formulate the hypothesis 
of bacterial CNG channel gating. In the absence of cAMP, the CNBDs are in the 
dimeric form and the channel is closed. Binding of cAMP prevents the CNBD 
dimerization and thus promotes the channel opening. This hypothesis fits and 
explains the available experimental data on channel function. Finally, the novel 
interface may be involved in some yet unknown interactions in cases where the 
CNBD function is not determined, as for CNBD-A domain of Epac2. 
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Fig. 1 Dimers of cyclic nucleotide binding domains observed in crystallographic structures. (a) 
Superposition of the cAMP-bound CNBD monomer (magenta) and the CNBD dimer in the 
absence of cAMP (green) for CNG ion channel MlotiK1 (PDB IDs 1VP6 and 3CO2). (b) 
Superposition of the cAMP-bound CNBD monomer (magenta) and the CNBD dimer in the 
absence of cAMP (green) for guanine nucleotide-exchange factor Epac2 (PDB IDs 3CF6 and 
1O7F) correspondingly. cAMP is shown in grey, in balls and sticks representation. Note that the 
presence of cAMP is incompatible with dimer formation. 
 
Fig. 2 RMSD of atomic coordinates of the backbone atoms during the trajectory of molecular 
dynamics simulations of MlotiK1 CNBD homodimer and Epac2 CNBD heterodimer. RMSD is 
measured relative to the initial (crystallographic) structures. 
 
Fig. 3 Backbone fluctuations as a function of the residue number. (a) MlotiK1 CNBD homodimer. 
(b) Epac2 CNBD heterodimer. Regions with defined secondary structures are highlighted. The 
secondary structure is labeled as in [7]. 
15 
 
Fig. 4 Structure of the alternative dimerization interface, proposed in the previous studies [7, 8] 
and its fluctuations during the molecular dynamics simulations. Fluctuations of the atomic 
coordinates of all the backbone atoms are shown. Two partial dissociation events are observed at 






Fig. 5 Principal components analysis of the simulated trajectories of MlotiK1 CNBD dimers that 
interact via the previously proposed interface or via the novel one. In the top row, the first 20 
eigenvalues of the mass-weighted covariation matrices are shown.  Note that the scales of the 
graphs are different. In the middle and the bottom rows, extreme projections of the trajectory on 
the corresponding eigenvectors are analyzed. In the middle row, there are the root mean square 
deviations of the backbone atoms of the protomers A and B, with the whole structure being aligned 
either by the protomer A or by the protomer B. It can be seen that the first three modes of the 
previously reported dimer trajectory correspond largely to the relative motions of the protomers. In 
the bottom row, backbone traces of the extreme conformations along the first three eigenvectors 
are shown for the both simulations. The structures are aligned by one of the protomers. The view is 
chosen so that the corresponding conformational changes are seen most clearly. 
17 
 
Fig. 6 Model of the bacterial CNG channel activation by cAMP. The view is from the cytoplasm 
perpendicular to the membrane plane. Only the pore helices S5 and S6 are shown. In absence of 
cAMP, the CNBDs are in dimers, the channel’s S6 helices are close to each other and the pore is 
occluded. In presence of cAMP, the CNBDs dissociate, and the ion pore opens. PDB IDs 2AHY 
and 3E86 were used to represent the closed and the open state of the pore correspondingly [33, 
34]. Helices of the voltage sensor-like domain are not shown. 
 
